Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Takeda Pharmaceutical Ord Shs
(OP:
TKPHF
)
27.55
-2.14 (-7.21%)
Streaming Delayed Price
Updated: 3:55 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Takeda Pharmaceutical Ord Shs
< Previous
1
2
Next >
Takeda's Maribavir Scores FDA Approval For Post-Transplant CMV Infection
November 24, 2021
The FDA has approved Takeda Pharmaceutical Co Ltd's (NYSE: TAK) Livtencity (maribavir) for a common type of viral infection occurring in patients after...
Via
Benzinga
Exposures
Product Safety
Takeda, Shattuck Labs Terminate Immuno-Oncology Pact
November 09, 2021
Shattuck Labs Inc (NASDAQ: STTK) and Takeda Pharmaceutical Co Ltd (NYSE: TAK) mutually agreed to terminate the Collaboration Agreement for SL-279252 and SL-115154...
Via
Benzinga
Takeda's 1H Sales Increase 13%, Reaffirms FY21 Outlook, Announces Share Buyback
October 28, 2021
Takeda Pharmaceutical Company Limited (NYSE: TAK) reported 1H FY21 sales of ¥1,794.4 billion, +12.8%. Underlying core revenue increased +6.8% Y/Y, driven by 14...
Via
Benzinga
Wave Life Sciences, Takeda Discontinue Research On Preclinical CNS Programs
October 19, 2021
Wave Life Sciences Ltd (NASDAQ: WVE) has amended its ongoing collaboration with Takeda Pharmaceutical Company Limited (NYSE: TAK) to discontinue...
Via
Benzinga
Calithera Buys Two Oncology Candidates From Takeda For $45M
October 19, 2021
Calithera Biosciences Inc (NASDAQ: CALA) has agreed to acquire two clinical-stage cancer-focused compounds from Takeda Pharmaceutical Company Limited (NYSE: TAK)....
Via
Benzinga
Takeda Discontinues Two Mid-Stage Narcolepsy Trials
October 06, 2021
Takeda Pharmaceutical Company Limited (NYSE: TAK) has suspended dosing and has decided to stop Phase 2 studies evaluating TAK-994, an investigational oral orexin...
Via
Benzinga
Takeda Says 'Human Error' Reason Behind Contaminated Moderna COVID-19 Vaccines
October 01, 2021
Takeda Pharmaceutical Co Ltd (NYSE: TAK) blamed "human error" as the cause of metal contaminants found in some batches of Moderna Inc's (NASDAQ: MRNA...
Via
Benzinga
Exposures
COVID-19
Takeda In-Licenses Hunter Syndrome Candidate
September 30, 2021
Takeda Pharmaceutical Company Limited (NYSE: TAK) and JCR Pharmaceuticals Co Ltd have announced an exclusive collaboration and license agreement to...
Via
Benzinga
Takeda Guilty Of Supply Contract Breach With AbbVie For Prostate Cancer Drug
September 24, 2021
In a spat between Takeda Pharmaceutical Co Ltd (NYSE: TAK) and AbbVie Inc (NYSE: ABBV) for Lupron (leuprorelin), a Delaware judge has issued a ruling in...
Via
Benzinga
Mirum, Takeda Ink Maralixibat Licensing Pact In Japan
September 21, 2021
Mirum Pharmaceuticals Inc (NASDAQ: MIRM) and Takeda Pharmaceutical Company Limited (NYSE: TAK) have entered into an exclusive licensing agreement for...
Via
Benzinga
Takeda's Breakthrough Blood Cancer Drug Flunks In Phase 3 Study
September 02, 2021
Takeda Pharmaceutical Co Ltd (NYSE: TAK) announced topline data from the Phase 3 PANTHER study evaluating pevonedistat in blood cancer indications. The trial did...
Via
Benzinga
UK's NICE Rejects Johnson & Johnson's Darzalex Regime For Newly Diagnosed Myeloma
August 30, 2021
New guidance from the National Institute for Health and Care Excellence (NICE) has rejected a combination regimen based on Johnson & Johnson's (NYSE: JNJ)...
Via
Benzinga
Moderna Withdraws Additional COVID-19 Shots In Japan: What You Need To Know
August 30, 2021
After receiving reports on more contaminated vials and two deaths, Japan has suspended another million doses of Moderna Inc's (NASDAQ: MRNA) COVID-19...
Via
Benzinga
Topics
Death
Exposures
COVID-19
Death
Exelixis - Takeda's Cabometyx Scores Approval In Japan For Kidney Cancer
August 26, 2021
Exelixis Inc's (NASDAQ: EXEL) collaborating partner Takeda Pharmaceutical Co Ltd (NYSE: TAK) and Ono Pharmaceutical Co Ltd have received...
Via
Benzinga
Takeda's Narcolepsy Candidate Gets FDA Breakthrough Therapy Tag
July 28, 2021
The FDA has granted Breakthrough Therapy Designation to Takeda Pharmaceutical Company Limited's (NYSE: TAK) TAK-994 for excessive daytime sleepiness (EDS...
Via
Benzinga
Exposures
Product Safety
Japan To Buy Additional 50M Doses Of Moderna COVID-19 Vaccine
July 20, 2021
Moderna Inc (NASDAQ: MRNA) has announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) and Takeda Pharmaceutical Co Ltd (NYSE: TAK) will...
Via
Benzinga
Exposures
COVID-19
Takeda's Dengue Vaccine Effective In Reducing Hospitalization Regardless Of Prior Infection
May 24, 2021
Takeda Pharmaceutical Co Ltd (NYSE: TAK) unveiled long-term data for its dengue vaccine candidate (TAK-003), showing the shot’s efficacy waned over time but...
Via
Benzinga
Takeda's Maribavir US Application For Post-Transplant CMV Infection Under Review
May 21, 2021
The FDA has accepted for review Takeda Pharmaceutical Co Ltd's (NYSE TAK) marketing application for maribavir for cytomegalovirus (CMV) Infection. The...
Via
Benzinga
Exposures
Product Safety
Moderna's COVID-19 Vaccine Scores Emergency Use Nod In Japan
May 21, 2021
Moderna Inc (NASDAQ: MRNA) has received emergency use approval for its mRNA COVID-19 vaccine in Japan. Takeda Pharmaceutical Co Ltd (NYSE: TAK),...
Via
Benzinga
Exposures
COVID-19
Takeda FY20 Profit Surges, Revenue Drops; Guides For Weak FY21 Profit
May 11, 2021
Takeda Pharmaceutical Co Ltd (NYSE: TAK) reported an FY20 net profit of ¥376 billion, a 750% Y/Y increase, reflecting gains on non-core asset sales and...
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.